Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2122
mi
from 91732
Clearwater, FL
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2122
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2318
mi
from 91732
Coral Gables, FL
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2318
mi
from 91732
Coral Gables, FL
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2555
mi
from 91732
Milford, MA
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2555
mi
from 91732
Milford, MA
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1489
mi
from 91732
Chaska, MN
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1489
mi
from 91732
Chaska, MN
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2409
mi
from 91732
Somers Point, NJ
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2409
mi
from 91732
Somers Point, NJ
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2433
mi
from 91732
Poughkeepsie, NY
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2114
mi
from 91732
Carnegie, PA
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2114
mi
from 91732
Carnegie, PA
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2116
mi
from 91732
Erie, PA
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2116
mi
from 91732
Erie, PA
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
5574
mi
from 91732
Gent,
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
5574
mi
from 91732
Gent,
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1786
mi
from 91732
Huntsville, AL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1786
mi
from 91732
Huntsville, AL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
343
mi
from 91732
Phoenix, AZ
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
20
mi
from 91732
Anaheim, CA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
20
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2131
mi
from 91732
Jacksonville, FL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2131
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2235
mi
from 91732
Melbourne, FL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2235
mi
from 91732
Melbourne, FL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2306
mi
from 91732
Pembroke Pines, FL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2306
mi
from 91732
Pembroke Pines, FL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1930
mi
from 91732
Stockbridge, GA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1930
mi
from 91732
Stockbridge, GA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1730
mi
from 91732
Chicago, IL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1617
mi
from 91732
Peoria, IL
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1617
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1798
mi
from 91732
South Bend, IN
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1798
mi
from 91732
South Bend, IN
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1331
mi
from 91732
Lenexa, KA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1331
mi
from 91732
Lenexa, KA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1186
mi
from 91732
Wichita, KA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1186
mi
from 91732
Wichita, KA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1647
mi
from 91732
Metairie, LA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1647
mi
from 91732
Metairie, LA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2274
mi
from 91732
Rockville, MD
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2274
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1570
mi
from 91732
Saint Louis, MO
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1570
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
911
mi
from 91732
Missoula, MT
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
911
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
214
mi
from 91732
Las Vegas, NV
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
214
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2412
mi
from 91732
Edison, NJ
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2412
mi
from 91732
Edison, NJ
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2433
mi
from 91732
Poughkeepsie, NY
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2244
mi
from 91732
Rochester, NY
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2217
mi
from 91732
Raleigh, NC
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2217
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2036
mi
from 91732
Cleveland, OH
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2116
mi
from 91732
Erie, PA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2116
mi
from 91732
Erie, PA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2042
mi
from 91732
Spartanburg, SC
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2042
mi
from 91732
Spartanburg, SC
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1762
mi
from 91732
Nashville, TN
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1211
mi
from 91732
Austin, TX
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1195
mi
from 91732
Fort Worth, TX
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1195
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1035
mi
from 91732
San Angelo, TX
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1035
mi
from 91732
San Angelo, TX
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2941
mi
from 91732
Halifax,
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2941
mi
from 91732
Halifax,
Click here to add this to my saved trials
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
Safety and Immunogenicity Study of GSK Biologicals' Cell Culture-based Influenza Virus Vaccine 1388442A Compared With US Licensed TIV in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
Safety and Immunogenicity Study of GSK Biologicals' Cell Culture-based Influenza Virus Vaccine 1388442A Compared With US Licensed TIV in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
Safety and Immunogenicity Study of GSK Biologicals' Cell Culture-based Influenza Virus Vaccine 1388442A Compared With US Licensed TIV in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1331
mi
from 91732
Lenexa, KA
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
Safety and Immunogenicity Study of GSK Biologicals' Cell Culture-based Influenza Virus Vaccine 1388442A Compared With US Licensed TIV in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1331
mi
from 91732
Lenexa, KA
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1788
mi
from 91732
Alabaster, AL
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1788
mi
from 91732
Alabaster, AL
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1786
mi
from 91732
Huntsville, AL
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1786
mi
from 91732
Huntsville, AL
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1754
mi
from 91732
Mobile, AL
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1754
mi
from 91732
Mobile, AL
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
356
mi
from 91732
Chandler, AZ
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
356
mi
from 91732
Chandler, AZ
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
365
mi
from 91732
Mesa, AZ
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
365
mi
from 91732
Mesa, AZ
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
343
mi
from 91732
Phoenix, AZ
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
353
mi
from 91732
Tempe, AZ
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
353
mi
from 91732
Tempe, AZ
Click here to add this to my saved trials